Search alternatives:
ejection » selection (Expand Search)
Showing 61 - 80 results of 104 for search '(preserved OR presented) left ventricular (ejection OR detection) function*', query time: 0.17s Refine Results
  1. 61

    A novel, non-invasive AI-based telemonitoring system for heart failure: detection of undiagnosed hyperthyroidism in an asymptomatic patient by Allan Böhm, Julia Lucka, Amitai Segev, Marta Kollarova, Stefan Toth, Nikola Jajcay, Branislav Bezak

    Published 2025-07-01
    “…As part of the evaluation of worsening of sub-clinical HF, extended laboratory tests revealed low thyroid-stimulating hormone with high free thyroxine levels indicating increased thyroid function. The endocrinologist diagnosed hyperthyroidism with multinodular goitre and prescribed thiamazole. …”
    Get full text
    Article
  2. 62

    STRUCTURAL AND FUNCTIONAL HEART PARAMETERS IN PATIENTS WITH CHRONIC HEART FAILURE DEPENDING ON DIFFERENT BLOOD MIDDLE MASS MOLECULES LEVELS by M. A. Kondratyuk, O. M. Radchenko

    Published 2015-09-01
    “…The patients with the highest MMM levels were specified by low left ventricular ejection fraction (p<0.05), the largest size of right ventricle, the lowest rate of preserved left ventricular function and high rate of diagnosis of increased sizes of the left atrium, interventricular septum and right ventricle.Conclusion. …”
    Get full text
    Article
  3. 63

    Cardiac structure and function in anabolic-androgenic steroid users: a 16-year follow-up study by Sigrun Halvorsen, Dan Atar, Anne Rossebø, Tea Sætereng Fyksen, Jørgen Gravning, Paul Vanberg, Ole Jørgen Grøtta

    Published 2025-08-01
    “…Despite higher cardiac troponin T levels in AAS users, coronary artery disease prevalence did not differ between groups.Conclusion Long-term AAS use was associated with myocardial remodelling and left ventricular dysfunction. In AAS users who discontinued use during follow-up, left ventricular remodelling and systolic function seemed to improve, even after more than a decade of AAS use.…”
    Get full text
    Article
  4. 64

    Multiparity induces persistent myocardial structural, functional and transcriptomic remodelling in mice by Ruth R. Magaye, Bing H. Wang, Hongyi R. Liu, Shanae Bailey, Rithy Nuon, Sabrina Sutano, Michael Nyugen, Helen Kiriazis, Kyah Grigolon, Luchen Shan, William W. H. Ho, Fumihiko Takeuchi, Daniel G. Donner, David M. Kaye

    Published 2025-07-01
    “…We evaluated blood pressure, body composition, gross weight and histologic cardiac structure. Cardiac function was assessed by echocardiography together with transcriptomic analysis of the left ventricular myocardium. …”
    Get full text
    Article
  5. 65

    Diastolic stress test in assessing functional state of postinfarction myocardium by A. M. Vorobev, V. I. Ruzov

    Published 2023-02-01
    “…Taking into account the conflicting literature data and the ambiguity in the interpretation of parameters of diastolic heart function in patients with coronary heart disease, we conducted an analysis of diastolic heart function in patients after myocardial infarction at the outpatient rehabilitation stage. …”
    Get full text
    Article
  6. 66
  7. 67

    Modern concept of diastolic heart failure by F. T. Ageev

    Published 1970-01-01
    “…The combination of classical and tissue Doppler ultrasound provides a more precise estimation of systolic and diastolic LV function. This method, in combination with natriuretic peptide level measurement, is the basis for the diagnostic algorithm of CHF with intact LVEF. …”
    Get full text
    Article
  8. 68
  9. 69

    Case of Dengue Myocarditis Mimicking as Acute Myocardial Infarction: A Diagnostic Dilemma by Priya Baluni, Shubhangi A Kanitkar, Prasad Chandrakant Bagare, Vanshaj Sharma

    Published 2025-05-01
    “…A 2D echocardiogram revealed mild left atrial dilation, preserved systolic function {Left Ventricular Ejection Fraction (LVEF) 55-60%} and paradoxical interventricular septal motion. …”
    Get full text
    Article
  10. 70

    Galectin-3 as a Marker of Cardiorenal Syndrome in Patients with Chronic Heart Failure by V. I. Podzolkov, N. A. Dragomiretskaya, A. V. Kazadaeva, Yu. G. Belyaev, A. V. Tolmacheva

    Published 2022-05-01
    “…Galectin-3 level in patients with HF is more influenced by the degree of reduction in GFR rather than the left ventricular systolic function impairment.…”
    Get full text
    Article
  11. 71

    New Clinical Aspects of Eplerenone Use in Clinical Practice by S. R. Gilyarevskiy, N. G. Bendeliani, M. V. Golshmid, I. M. Kuzmina

    Published 2018-09-01
    “…The main goal of this study was to evaluate the efficacy of eplerenone compared with placebo in patients with heart failure and reduced left ventricular function. In addition, experimental animal studies, which may indicate the pleiotropic effects of eplerenone in patients with vascular diseases, are presented. …”
    Get full text
    Article
  12. 72
  13. 73

    New possibilities of nephroprotection in patients with chronic heart failure in combination with chronic kidney disease and diabetes mellitus 2 or without it by E. V. Kovalenko, L. I. Markova, O. L. Belaya

    Published 2022-10-01
    “…Impaired kidney function has a negative impact on the course of heart failure in both patients with and without diabetes mellitus. …”
    Get full text
    Article
  14. 74
  15. 75

    Echocardiographic predictors of mortality in heart failure from Chagas cardiomyopathy: Refining risk stratification with speckle-tracking echocardiography by Marcelo Alves Maia, Ester Cerdeira Sabino, Jose Luiz Padilha da Silva, Cesar Augusto Taconeli, Lea Campos de Oliveira, Omar Ribeiro Santos Junior, Ana Isabel Nobre Maia, Fellipe Colares P.G. Versiani, Ariela Mota Ferreira, Antonio Luiz P. Ribeiro, Maria Carmo P. Nunes

    Published 2025-09-01
    “…Background: Chagas cardiomyopathy is a major cause of mortality in endemic regions, predicted primarily by left ventricular (LV) systolic function. Speckle-tracking echocardiography (STE)–derived strain is a sensitive tool for assessing ventricular function and may enhance risk stratification. …”
    Get full text
    Article
  16. 76

    Evaluation of the relationship of immuno-inflammatory process with dyslipidemia and myocardial morphofunctional parameters in patients with chronic heart failure on the background... by A. S. Ankudinov, A. N. Kalyagin

    Published 2020-09-01
    “…The study involved 57 women with CHF-SFV, formed as a result of coronary heart disease and/or hypertension. All patients had functional class I and II according to NYHA. All patients were divided into comparable groups: the first group included 31 patients with a combination of CHF and seropositive RA of radiological stage I-III, the second group included 26 patients without RA. …”
    Get full text
    Article
  17. 77

    Damage to the Cardiovascular System in Patients with SARS-CoV-2 Coronavirus Infection. Part 2: Correction of Myocardial Systolic Dysfunction by V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, I. I. Shvedov, E. E. Bykova, A. A. Ivannikov, L. V. Vasilyeva

    Published 2022-05-01
    “…Assessment of LV systolic function, exercise tolerance (six-minute walk test, TSW), quality of life (questionnaire EQ-5D-5L) were performed.Results. …”
    Get full text
    Article
  18. 78

    Pulmonary artery banding for dilated cardiomyopathy in children: report of 3 cases by Linghan Meng, Qingyu Gao, Zhanhui Du, Ping Yang, Lijuan Zong, Bei Lv, Quansheng Xing

    Published 2025-07-01
    “…All three patients had previously received standard medical therapy, but experienced progressive cardiac enlargement and declining function. Preoperative left ventricular ejection fraction (LVEF) was 25% in Case 1, 21% in Case 2 and 44% in Case 3. …”
    Get full text
    Article
  19. 79

    When viral myocarditis meets thrombosis tendency: deep analysis of a complex case report by Qian Ding, Yun Zhang, Dongbei Li, Wenhua Liu, Jing Feng, Shuang Li, Wei Chen, Mu Guo

    Published 2025-08-01
    “…Following treatment, inflammatory markers and coagulation function improved, cardiac function recovered (LVEF increased to 53%), and the thrombus resolved. …”
    Get full text
    Article
  20. 80

    Effects of dapagliflozin on blood volume status and vascular outcomes in clinically stabilized heart failure patients after an acute decompensated heart failure event (DAPA-VOLVO s... by Konstantinos Bitos, Natallia Laptseva, Thomas Haider, Valentina A Rossi, Matthias P Nägele, Jens Barthelmes, Frank Ruschitzka, Isabella Sudano, Andreas J Flammer

    Published 2025-01-01
    “…<h4>Methods</h4>Eighty adult patients with diagnosis of de novo or chronic HF (NYHA class II-IV), clinically stabilized after an ADHF event and with preserved renal function, who were not on treatment with SGLT-2i, are aimed to be included. …”
    Get full text
    Article